alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|   | (1) | The Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2009 (the “Report”) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

| February 5, 2010 |   | /s/Phillip E. Becker                  |
|------------------|--------|---------------------------------------|
| Date             |   | Phillip E. Becker                     |
|             |   | President and Chief Executive Officer |
|             |   |                                  |
|             |   |                                  |
|             |   |                                  |
| February 5, 2010 |   | /s/H. Stewart Fitz Gibbon III         |
| Date             |   | H. Stewart Fitz Gibbon III            |
|             |   | Executive Vice President and          |
|             |   | Chief Financial Officer               |
# 

# CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

Registration No.  333-97047

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  327                                                                   Trade Date:  08/25/03

(To Prospectus Supplement dated August 15, 2002 &

  Prospectus dated August  8,2002)                                                                Issue Date:   08/28/03

The Date of this Pricing SupplementAugust 25, 2003

SUBJECT TO REDEMPTION OR REPAYMENT

 CUSIP                                                                                                                                   Date and terms of redemption or

     or       Stated                                                                   Interest                                       repayment (includingany

Common  Interest                      Price to  Discounts &        Payment     Survivors                  applicable regular or special

  Code      Rate (1)   Maturity  Public (2) Commissions       Frequency       Option  Yes/No     record dates)

14911QPQ8   4.00%        08/15/09           100%              1.1%                   Quarterly                      YES          NO                

                       

                          

Principal                                                                                 1st Payment             Day         

Amount                  Proceeds                  Dealer                           Date                   Count

$2,946,000.00         $2,913,594.00         ABN AMRO Inc.        11/15/03                               30/360    

Original Issue DiscountNote:                                                                          Total Amount of OID:

____  Yes                X   No                                                                                  N/A

The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.  Prior to the date of this Pricing Supplement, $239.678 mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (SM) will be made under the Prospectus Supplement and Prospectus dated August 8,2002.

Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
From: abneyenv@embarqmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:21:38 PM

To Whom It May Concern:

HHS has issued a mandate that is immoral and unjust in that it will require all "contraceptives" and

sterilization procedures be covered by private health insurance with no co-pay to patients. That will

include chemicals that can cause abortion. I strongly object to that mandate. I strongly oppose the

government forcing "free" insurance coverage on Americans especially for drugs and devices that I

oppose because some of these can cause an abortion (such as ella and Plan B).

If you do not reverse course I ask you to expand conscience protections for any organizations that

provide individual and/or group insurance and have moral or religious objections to that mandate.

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

organized churches, but will still mean that a host of businesses and organizations that have conscience

objections will be required to choose between either violating their conscience or not being able to offer

employees health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services to which they have religious objections. I

implore you to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Jack Abney

Naples, FL 34108
From: ddqj4@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:00:49 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Dwight McDaniel

Robinson, IL 62454
Exhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, James P.
Panek, certify that: 1.
I have
  reviewed this quarterly report on Form 10-Q of VaxGen, Inc.2.
Based on my
  knowledge, this report does not contain any untrue statement of a material fact
  or omit to state a material fact necessary to make the statements made, in
  light of the circumstances under which such statements were made, not
  misleading with respect to the period covered by this report;3.
Based on my
  knowledge, the financial statements, and other financial information included
  in this report, fairly present in all material respects the financial
  condition, results of operations and cash flows of the registrant as of, and
  for, the periods presented in this report;4.
The registrants
  other certifying officer and I are responsible for establishing and
  maintaining disclosure controls and procedures (as defined in Exchange Act
  Rules 13a-15(e) and 15d-15(e)) for the registrant and have:(a) Designed
  such disclosure controls and procedures, or caused such disclosure controls
  and procedures to be designed under our supervision, to ensure that material
  information relating to the registrant, including its consolidated
  subsidiaries, is made known to us by others within those entities,
  particularly during the period in which this report is being prepared;(b)
  [Reserved];(c)
  Evaluated the effectiveness of the registrants disclosure controls and
  procedures and presented in this report our conclusions about the effectiveness
  of the disclosure controls and procedures, as of the end of the period
  covered by this report based on such evaluation; and(d)
  Disclosed in this report any change in the registrants internal control over
  financial reporting that occurred during registrants most recent fiscal
  quarter (the registrants fourth quarter in the case of an annual report)
  that has materially affected, or is reasonably likely to materially affect,
  the registrants internal control over financial reporting; and5.
The
  registrants other certifying officer and I have disclosed, based on our most
  recent evaluation of internal control over financial reporting, to the
  registrants auditors and the audit committee of registrants board of
  directors (or persons performing the equivalent functions):(a) All
  significant deficiencies and material weaknesses in the design or operation
  of internal control over financial reporting which are reasonably likely to
  adversely affect the registrants ability to record, process, summarize and
  report financial information; and(b) Any
  fraud, whether or not material, that involves management or other employees
  who have a significant role in the registrants internal control over
  financial reporting. February 6, 2007 /s/ James P. PanekChief Executive Officer - 1 -
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on July 12, 2023, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), Open RF Association, Inc. filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages                           ( print page 66057)                        under specified circumstances. Specifically, Zeku Technology (Shanghai) Corp., Ltd., Shanghai, PEOPLE'S REPUBLIC OF CHINA has withdrawn as a party to this venture.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Open RF Association, Inc. intends to file additional written notifications disclosing all changes in membership.

                    On February 21, 2020, Open RF Association, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to section 6(b) of the Act on March 11, 2020 (85 FR 14247).                

                    The last notification was filed with the Department on April 27, 2023. A notice was published in the                     **Federal Register**                     pursuant to section 6(b) of the Act on June 13, 2023 (88 FR 38533).                

Suzanne Morris,

Deputy Director Civil Enforcement Operations, Antitrust Division.

[FR Doc. 2023-20778 Filed 9-25-23; 8:45 am]

BILLING CODE P
Exhibit 99.1







The First Bancorp Declares Dividend








DAMARISCOTTA, Maine – (BUSINESS WIRE) – March 17, 2011 – The Board of Directors of The First Bancorp (NASDAQ: FNLC), today declared a quarterly dividend of 19.5 cents per share. This first-quarter dividend, which is payable April 29, 2011, to shareholders of record as of April 6, 2011, is equal to the 19.5 cents per share declared in the previous ten quarters.




“The combination of good earnings and strong capital ratios enable us to maintain our dividend at its current level,” stated Daniel R. Daigneault, the Company’s President & Chief Executive Officer. “Many of our shareholders invest in The First Bancorp because of our generous dividend, and maintaining the ability to pay this dividend is one of the major focuses of the Board and Management.”




The First Bancorp, headquartered in Damariscotta, Maine, is the holding company for The First, N.A. Founded in 1864, The First is an independent community bank serving Mid-Coast and Down East Maine with 14 offices in Lincoln, Knox, Hancock and Washington Counties. The Bank provides a full range of consumer and commercial banking products and services. First Advisors, a division of The First, provides investment advisory, private banking and trust services from two offices in Lincoln and Hancock Counties.




Forward-looking and cautionary statements: except for the historical information and discussions contained herein, statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially, as discussed in the Company’s filings with the Securities and Exchange Commission.




For more information, please contact F. Stephen Ward, the First Bancorp’s Treasurer & Chief Financial Officer, at 207.563.3272.
#### UNITED STATES of America, Plaintiff-Appellee, v. Juan Martin BARRIENTOS, Defendant-Appellant.

No. 01-10004.

D.C. No. CR-99-00351-SOM.

United States Court of Appeals, Ninth Circuit.

Submitted June 11, 2001.*

Decided June 25, 2001.

*552Before O’SCANNLAIN, SILVERMAN, and GOULD, Circuit Judges.

*

 The panel unanimously finds this case suitable for decision without oral argument. See Fed. R.App. P. 34(a).

MEMORANDUM **

Juan Martin Barrientos appeals the district court’s application of U.S.S.G. § 2B3.1(b)(2)(F) which increased the level of his sentence for robbery. Section 2B3.1(b)(2)(F) provides for a two level enhancement in robbery sentences where an offender is found to have made a threat of death during the offense.

The district court held that slipping a bank teller a note which read “Give me all your money. I have a gun” was a threat of death. A threat of death exists where a reasonable person would perceive the threat of death. *See*U.S.S.G. § 2B3.1, cmt. n. 6 (“the intent of this provision is to provide an increased offense level for cases in which the offender(s) engaged in conduct that would instill in a reasonable person, who is a victim of the offense, a fear of death”); *see also United States v. France,*57 F.3d 865, 868 (9th Cir.1995) (upholding enhancement where a note stated “Give me all the 100s and 50s in your drawer. I have dynamite” under a prior similar version of section 2B3.1(b)(2)(F)). The district court’s finding that Barrientos’ note would reasonably instill in a victim a fear of death was not clearly erroneous.

AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by 9th Cir. R. 36-3.
From: mary.ellen5@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:55:03 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Mary Smolinski

Immokalee, FL 34142
Exhibit
32.1
 
 Certification
of Chief Executive Officer and Chief Financial Officer
 Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
 
 I, Lars
Pearl, President, Chief Executive Officer and  Chief Financial Officer
of Aurora Gold Corporation (the “Company”), certify, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
 1.
              The
      Quarterly Report on Form 10-Q of the Company for the period ended
      September 30, 2008 which this certification accompanies fully complies
      with the requirements of section 13(a) or 15(d) of the Securities Exchange
      Act of 1934: and
 
 2.
              The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.
 
 
 Date:November
      14, 2008
                    
                    BY:
                    /s/ Lars PearlLars
      PearlPresident,
      CEO and CFO
 
 
 This
certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended. A
signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

JAMES R. BROWN,

Petitioner-Appellant,

v.

No. 95-2174

COMMISSIONER OF THE INTERNAL

REVENUE SERVICE,

Respondent-Appellee.

Appeal from the United States Tax Court.

(Tax Ct. No. 92-20023)

Argued: May 6, 1996

Decided: September 5, 1996

Before ERVIN and WILKINS, Circuit Judges, and NORTON,

United States District Judge for the District of South Carolina,

sitting by designation.

_________________________________________________________________

Reversed by unpublished per curiam opinion.

_________________________________________________________________

COUNSEL

ARGUED: Paula Marie Junghans, MARTIN, JUNGHANS, SNYDER & BERNSTEIN, P.A., Baltimore, Maryland, for Appellant. William J. Patton, Tax Division, UNITED STATES DEPARTMENT OF

JUSTICE, Washington, D.C., for Appellee. ON BRIEF: Loretta C.

Argrett, Assistant Attorney General, Gary R. Allen, Richard Farber,

Tax Division, UNITED STATES DEPARTMENT OF JUSTICE,

Washington, D.C., for Appellee.

_________________________________________________________________
Unpublished opinions are not binding precedent in this circuit. See

Local Rule 36(c).

_________________________________________________________________

OPINION

PER CURIAM:

James R. Brown appeals a decision of the United States Tax Court

upholding a determination by the Commissioner of Internal Revenue

that a distribution Brown received in 1989 from the Maryland Teachers' Retirement System was taxable income to him in that year. We

note that the material facts presented here are indistinguishable from

those we addressed in Adler v. Commissioner, 86 F.3d 378 (4th Cir.

1996), in which we held that a distribution from the Maryland

Employees' Retirement System was entitled to rollover treatment

under 26 U.S.C.A. § 402(a)(5) (West 1988). The parties agree that the

distribution Brown received was a partial distribution from a qualified

plan, that he transferred the entire previously-untaxed portion of the

distribution ($149,283.76) to an eligible individual retirement account

within 60 days of receiving the payment, and that his retirement qualifies as a "separation from the service." See 26 U.S.C.A. § 402(a)(5),

(e)(4)(A)(iii). Therefore, Brown's distribution was entitled to rollover

treatment if he received it "on account of" his retirement. Id.

§ 402(e)(4)(A)(iii). As did the taxpayer in Adler, Brown elected, in

connection with his retirement, to transfer to a pension system, resulting in his receipt of the distribution; accordingly, he received the distribution "on account of" his retirement within the meaning of 26

U.S.C.A. § 402(e)(4)(A)(iii). See Adler , 86 F.3d at 381. For the reasons set forth in Adler, we reverse.

REVERSED

 2